ArticleTriple therapy: Boon or bane for high-risk CV patients?Author:Candace B. Griffith, PharmD Publish date: April 1, 2011 The combination of 2 antiplatelet agents and warfarin may be beneficial to a select group of patients, but its use remains controversial. Here&rsq... Read More
